Medpace Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Medpace Holdings, Inc. (MEDP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 10.86 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-07-23
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 2.24K shares, a 11.80% increase year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 2.35K shares, a 20.42% decline year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 6.20K shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was 2.00K shares, a 60.00% increase year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 32.28K shares, a 72.85% decline from fiscal 2020.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 118.89K shares, a 68.34% decline from fiscal 2019.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 375.56K shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 90.56K shares, a 46.34% decline from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 10.86K shares 10-Q · filed 2026-07-23 | |||
| 2025-09-30 | 2.24K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | 4.59K shares derived: sum of 2 quarters · filed 2025-10-23 | 10.79K shares 10-Q · filed 2025-10-23 | |
| 2025-06-30 | 2.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | 8.55K shares 10-Q · filed 2025-07-22 | ||
| 2025-03-31 | 6.20K shares 10-Q · filed 2025-04-22 | |||
| 2024-09-30 | 2.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | 4.95K shares derived: sum of 2 quarters · filed 2024-10-22 | 4.95K shares 10-Q · filed 2024-10-22 | |
| 2024-06-30 | 2.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | 2.95K shares 10-Q · filed 2024-07-23 | ||
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-04-23 | |||
| 2023-09-30 | 1.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | 6.75K shares derived: sum of 2 quarters · filed 2023-10-24 | 9.75K shares 10-Q · filed 2023-10-24 | |
| 2023-06-30 | 5.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | 8.50K shares 10-Q · filed 2023-07-25 | ||
| 2023-03-31 | 3.00K shares 10-Q · filed 2023-04-25 | |||
| 2022-09-30 | 5.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | 13.20K shares derived: sum of 2 quarters · filed 2022-10-25 | 28.75K shares 10-Q · filed 2022-10-25 | 35.10K shares derived: sum of 4 quarters · filed 2022-10-25 |
| 2022-06-30 | 7.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | 22.95K shares 10-Q · filed 2022-07-26 | 29.30K shares derived: sum of 3 quarters · filed 2022-07-26 | 33.90K shares derived: sum of 4 quarters · filed 2022-07-26 |
| 2022-03-31 | 15.55K shares 10-Q · filed 2022-04-26 | 21.90K shares derived: sum of 2 quarters · filed 2022-04-26 | 26.50K shares derived: sum of 3 quarters · filed 2022-04-26 | |
| 2021-12-31 | 6.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 10.95K shares derived: sum of 2 quarters · filed 2022-02-15 | 32.28K shares 10-K · filed 2022-02-15 | |
| 2021-09-30 | 4.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | 25.93K shares 10-Q · filed 2021-10-26 | ||
| 2021-06-30 | 21.33K shares 10-Q · filed 2021-07-27 | |||
| 2020-12-31 | 118.89K shares 10-K · filed 2022-02-15 | |||
| 2019-12-31 | 375.56K shares 10-K · filed 2022-02-15 | |||
| 2017-03-31 | 49.83K shares 10-Q · filed 2017-05-02 | |||
| 2016-12-31 | 90.56K shares 10-K · filed 2017-02-28 | |||
| 2015-12-31 | 168.78K shares 10-K · filed 2017-02-28 | |||
| 2014-12-31 | 40.85K shares 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |